21.09.2022 • News

Roquette Acquires Indian Excipient Manufacturer

Roquette, a French-based provider of pharmaceutical and nutraceutical excipients, has acquired Crest Cellulose, an Indian excipient manufacturer, reinforcing its presence in India and Asia.

© Roquette
© Roquette

The move follows Roquette’s purchase of a majority stake in Crest Cellulose from Indian pharma packaging company Pravesha Industries in December 2018. A privately owned company based in Mumbai, Crest Cellulose has locations in Hyderabad and Nellore, manufacturing a wide range of “superior” excipients.

“The team at Crest Cellulose share our conviction that quality is king, always striving to optimize processes and redefine what’s possible in drug delivery. As a global leader in health and nutrition, we’re excited to harness our newly expanded capabilities to support our network of customers and partners in India, Asia and the rest of the world,” said Paul Smaltz, vice president at Roquette Pharma Solutions.

According to Roquette, India’s pharma industry is poised for a period of seismic growth and production of generics in the Asia-Pacific region is also expanding.  

Author: Elaine Burridge, Freelance Journalist

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Interview

Leading Transformation
The Path to Sustainable Growth

Leading Transformation

As Executive Vice President of International Chemicals since early 2024, Antje Gerber has been steering Sasol through a pivotal reset—focused on resilience, innovation, and bold sustainability goals.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.